Synthesis and biological evaluation of isoxazoline and isoxazole derivatives as 5-HT2A and 5-HT2C receptor ligands

Bulletin of the Korean Chemical Society

Volumn 30, Issue 8, 2009, Pages 1873-1876

  Youn, Hae Suk ^a   Lee, Eun Ju ^b   Lee, Jie Eun ^a,c   Park, Woo Kyu ^d   Baek, Du Jong ^b   Cho, Yong Seo ^a   Koh, Hun Yeong ^c   Choo, Hyunah ^a   Pae, Ae Nim ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Sangmyung University   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

^d Inha University   (South Korea)

Author keywords

Antidepressant; Isoxazole; Isoxazoline; Serotonin; Serotonin receptor

Indexed keywords

EID: 75649131487     PISSN: 02532964     EISSN: 12295949     Source Type: Journal    
DOI: 10.5012/bkcs.2009.30.8.1873     Document Type: Article

References (22)

1. Artigas, F.; Nutt, D.J.; Shelton, R. Psychopharmacology Bull. 2002, 36, 123.
2. Gillman, P.K. Brit. J. Pharmacol. 2007, 151, 737.
3. Lane, R.; Baldwin, D.; Preskorn, S.J. Psychopharmacology 1995, 9, 163.
4. Montgomery, S. Int. J. Psychiat. Clin. 2006, 10, 5.
5. Adell, A.; Castro, E.; Celada, P.; Bortolozzi, A.; Pazos, A.; Artigas, F. Drug Discov. Today 2005, 10, 578.
6. Romero, L.; Celada, P.; Martin-Ruiz, R.; Diaz-Mataix, L.; Mourelle, M.; Delgadillo, J.; Hervas, I.; Artigas, F. Neuropsychopharmacology 2003, 28, 445.
7. Boothman, L.; Mitchell, S.N.; Sharp, T. Neuropharmacology 2006, 50, 726.
8. Boothman, L.; Allers, K.A.; Rasmussen, K.; Sharp, T. Brit. J. Pharmacol. 2004, 139, 998.
9. Stout, S.C.; Owens, M.J.; Nemeroff, C.B. Ann. Rev. Pharmacol. Toxicol. 2001, 41, 877.
10. Overstreet, D.H.; Griebel, G. Eur. J. Pharmacol. 2004, 497, 49.
11. Sharp, T.; Boothman, L.; Raley, J.; Queree, P. TRENDS Pharmacol. Sci. 2007, 28, 629.
12. Temel, Y.; Boothman, L.J.; Blokland, A.; Magill, P.J.; Steinbusch, H.W.M.; Visser-Vandewelle, V.; Sharp, T. PNAS 2007, 104, 17087.
13. Artigas, F.; Bortolozzi, A. Neuropsychopharmacology 2003, 28, 421.
14. Bala, K.; Hailes, H.C. Synthesis 2005, 19, 3423.
15. Browne, M.F.; Shriner, R.L. J. Org. Chem. 1957, 22, 1320.
16. David, A.; Steer, D.; Bregant, S.; Devel, L.; Makaritis, A.; Beau, F.; Yiotakis, A.; Dive, V. Angew. Chem. Int. Ed. 2007, 46, 3275.
17. Cha, M.Y.; Choi, B.C.; Kang, K.H.; Pae, A.N.; Choi, K.Y.; Cho, Y.S.; Koh, H.Y.; Lee, H.-Y.; Jung, D.; Kong, J.Y. Bioorg. Med. Chem. Lett. 2002, 12, 1327.
18. Abdel-Magid, A.F.; Carson, K.G.; Harris, B.D.; Maryanoff, C.A.; Shah, R.D. J. Org. Chem. 1996, 61, 3849.
19. Pazos, A.; Hoyer, D.; Palacios, J.M. Eur. J. Pharmacol. 1985, 106, 539.
20. Park, W.K.; Jeong, D.; Cho, H.; Lee, S.J.; Cha, M.Y.; Pae, A.N.; Choi, K.I.; Koh, H.Y.; Kong, J.Y. Pharmacol. Biochem. Behav. 2005, 82, 361.
21. Borsini, F.; Meli, A. Phychopharmacology 1988, 94, 147.
22. Porsolt, R.D.; Bertin, A.; Jalfre, M. Arch. Int. Pharmacodyn. Ther. 1977, 229, 327.